Compounds > dabigatran
Page last updated: 2024-09-05

dabigatran and Telangiectasia, Hereditary Hemorrhagic

dabigatran has been researched along with Telangiectasia, Hereditary Hemorrhagic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buscarini, E; Coote, N; Droege, F; Dupuis-Girod, S; Fialla, AD; Geisthoff, U; Kjeldsen, A; Lenato, GM; Mager, HJ; Manfredi, G; Millar, CM; Pagella, F; Post, MC; Sabbà, C; Shovlin, CL; Suppressa, P; Sure, U; Torring, PM; Ugolini, S1
Devlin, HL; Hosman, AE; Shovlin, CL1

Other Studies

2 other study(ies) available for dabigatran and Telangiectasia, Hereditary Hemorrhagic

ArticleYear
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia.
    Orphanet journal of rare diseases, 2019, 08-28, Volume: 14, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Epistaxis; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Telangiectasia, Hereditary Hemorrhagic; Venous Thromboembolism; Warfarin

2019
Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia.
    The New England journal of medicine, 2013, Feb-28, Volume: 368, Issue:9

    Topics: Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Platelet Aggregation Inhibitors; Telangiectasia, Hereditary Hemorrhagic; Warfarin

2013